Two Sigma Investments
VIGL

Two Sigma Investments’s Vigil Neuroscience VIGL Stock Holding History

Two Sigma Investments’s Portfolio VIGL Stock Details VIGL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-136,920
Closed -$233K – 3506
2024
Q4 		$233K Buy
136,920
+41,836
+44% +$124K ﹤0.01% 2823
2024
Q3 		$323K Buy
95,084
+83,019
+688% +$308K ﹤0.01% 2647
2024
Q2 		$48.3K Sell
12,065
-32,933
-73% -$113K ﹤0.01% 2889
2024
Q1 		$153K Buy
44,998
+29,270
+186% +$91.4K ﹤0.01% 2775
2023
Q4 		$53.2K Buy
+15,728
New +$80.9K ﹤0.01% 2991

Other funds holding VIGL

AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $790M AUM 223.66% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $61.9B AUM 29.81% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $630M AUM 108.65% 1-Year Est. Return
Ensign Peak Advisors
Ensign Peak Advisors Salt Lake City, Utah $53.7B AUM 29.47% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return
PBPIA
Pivotal bioVenture Partners Investment Advisor San Francisco, California $280M AUM 181.4% 1-Year Est. Return

Two Sigma Investments's VIGL Position: Q1 2025 in Review

Two Sigma Investments sold out of Vigil Neuroscience (VIGL) in Q1 2025, closing a stake of 136,920 shares — an estimated $233K sold.

Two Sigma Investments first reported a position in VIGL in Q4 2023 and held it in 5 quarters. The position peaked at $323K in Q3 2024. 50 funds tracked by Wall St. Rank hold VIGL as of Q1 2025.

  • Two Sigma Investments reported no remaining Vigil Neuroscience position as of Q1 2025 after selling out during the quarter.
  • Two Sigma Investments sold 136,920 Vigil Neuroscience shares in Q1 2025, an estimated $233K.
  • Two Sigma Investments first reported a position in Vigil Neuroscience in Q4 2023 and held it in 5 quarters.
  • Two Sigma Investments's Vigil Neuroscience position peaked at $323K in Q3 2024.
  • 50 funds tracked by Wall St. Rank held Vigil Neuroscience as of Q1 2025.

Based on Two Sigma Investments's 13F filing for Q1 2025, filed 15 May 2025.